Clofarabine Has Apoptotic Effect on T47D Breast Cancer Cell Line via P53R2 Gene Expression.
2015
Purpose: Clofarabine,
a purine nucleoside analogue and inhibitor of Ribonucleotide Reductase (RR), is
used for treatment of leukemia. Clofarabine-induced defect in DNA replication,
induces p53 and subsequently P53R2 genes as subunit of RR. clofarabine
deregulated P53R2 gene expression leading to the elevated levels of P53R2 which
impose resistance to DNA damaging drugs. In this study the apoptotic and
cytotoxic effects of clofarabine has been investigated on breast cancer cell
line.
Methods: Cofarabine
cytotoxicity on T47D cells has been studied by MTT assay. T47D cells were
exposed to the different concentrations of clofarabine for 24, 48 and 72 hours
intervals. Relative expression of P53R2 gene has been studied using real-time
PCR. Moreover, after treating with clofarabine the apoptotic and necrotic cells
were detected using Annexin V and propodium iodide (PI) reagents by
flowcytometry technique.
Results: MTT assay
results showed that the clofarabine IC50 on T47D cell line were 3 and 2.5µM
after 48 and 72 h exposure, respectively. Clofarabine did not show any
significant cytotoxic effect after 24 h exposure. The analysis of qRT-PCR
showed a significant increase in P53R2 gene expression in treated cells with
both 2.5 and 3 μM doses and also, the results of flowcytometry revealed 26.91
and 74.46 percent apoptosis induction in 48 and 72h treatments respectively in
comparison to the control groups.
Conclusion: Our results showed that apoptotic and cytotoxic effects of clofarabine
on T47D cell line were in time and dose dependent manner; therefore it could be
considered a new candidate in breast cancer therapy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
3
Citations
NaN
KQI